Nektar Therapeutics | Attività Correnti



Current Assets Cambiamento Data
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
ALKERMES USD 1.48B 63.7M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Baxter International USD 8.85B 11M 2024-12
Biogen USD 7.63B 169.2M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Cipla INR 232.89B 23.43B 2025-03
Dr.Reddys Laboratories INR 250.18B 2.84B 2025-03
Eisai JPY 727.66B 33.44B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Exelixis USD 1.4B 71.08M 2025-04
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Grifols EUR 5.73B 404.28M 2024-12
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
Incyte USD 3.23B 7.24M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 35.5B 3.28B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Takeda JPY 2.52T 233.1B 2025-03
Teva Pharmaceutical Industries USD 11.53B 1.02B 2025-03
Xencor USD 521.27M 56.33M 2025-03



Nektar Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.